An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

March 31, 2009

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

ASA404

Trial Locations (4)

Novartis Investigative Site, Aichi

Novartis Investigative Site, Osaka

Novartis Investigative Site, Shizuoka

Novartis Investigative Site, Tokyo